Human clinical trial aimed at evaluating antioxidative effect and safety of Hydrogen Coral Powder

Human clinical trial aimed at evaluating antioxidative effect and safety of Hydrogen Coral Powder - Human clinical trial of Hydrogen Coral Powder

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000026913

Enrollment

Registered

2017-04-10

Start date

2015-09-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adults in good health condition

Interventions

Intake 2g of Hydrogen Coral Powder (Pure Ash Coral) per day (1g before breakfast and 1g before dinner) for 6 months.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Not under 20 years old when giving consent. Critical hepatic dysfunction and/or critical renal dysfunction not to be observed at screening test. Person who give first-person consent in writing.

Exclusion criteria

Exclusion criteria: Person who are obviously not able to visit hospital during the trial. Person whom doctor-in-charge judges the one is unsuitable for this trial.

Design outcomes

Primary

Measure	Time frame
Intake method: 2g daily Intake period: 6 months Measuring method: blood pressure check, pulse check, body temperature check Blood test, Measuring 8-OHdG creatinine ratio in urine.	—

Countries

Japan

Contacts

Public ContactMakiko Ido

First CO., Ltd. Sales Department

info@suiso1st.co.jp03-5475-8967

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026